苦瓜MAP30蛋白的原核表达及其生物活性研究

doi:10.13523/j.cb.20140606

中国生物工程杂志

2014, Vol. 34

Issue (06): 40-46 DOI: 10.13523/j.cb.20140606

研究报告

苦瓜MAP30蛋白的原核表达及其生物活性研究

邱华丽¹, 穰杰¹, 丁学知¹, 胡胜标¹, 张友明¹, 朱道奇², 夏立秋¹

1. 湖南师范大学生命科学学院长沙 410081;
2. 湖南师范大学第二附属医院长沙 410003

Prokaryotic Expression of MAP30 from Momordica charantia and Its Biological Activity

QIU Hua-li¹, RANG Jie¹, DING Xue-zhi¹, HU Sheng-biao¹, ZHANG You-ming¹, ZHU Dao-qi², XIA Li-qiu¹

1. College of Life Science, Hunan Normal University, Changsha 410081, China;
2. The Second Affiliated Hospital of Hunan Normal University, Changsha 410003, China

全文: PDF(1557 KB) HTML

摘要：

以天然苦瓜基因组为模板PCR扩增去前导肽后成熟的MAP30蛋白基因，克隆至可诱导表达载体pET28a中。将含MAP30基因的表达载体pET28a-MAP30转化至E. coli Rostta（DE3）中并通过IPTG诱导表达。经聚丙烯酰胺凝胶电泳（SDS-PAGE）和蛋白杂交（Western blot）以及液相色谱-质谱（LC-MS）对表达的重组MAP30蛋白进行鉴定，并通过镍柱亲和层析纯化。将pUC19质粒与不同浓度的纯化后的重组MAP30蛋白孵育，分析其切割DNA的活性。同时将纯化后的重组MAP30蛋白体外作用于人乳腺癌细胞（MCF-7），采用MTT、AO/PI双染等方法进行抗肿瘤活性分析。实验结果表明纯化后的蛋白经质谱鉴定和Western blot分析，目的蛋白成功地与His-tag融合表达。首次发现大肠杆菌异源表达的重组MAP30蛋白同天然蛋白一样可以切割超螺旋DNA活性。MTT、AO/PI双染结果证实重组MAP30体外可诱导MCF-7细胞发生凋亡。通过基因工程技术大量制备MAP30蛋白，进一步研究其体外生物学活性，为以后的临床应用奠定基础。

关键词： 核糖体失活蛋白; 基因工程; DNA切割; 细胞凋亡

Abstract:

Mature map30(signal peptide sequence excluded) was amplified from the genome of bitter melon and inserted on the expression vector pET28a. The final expression vector pET28a-map30 was transformed into E. coli Rostta (DE3) for MAP30 expression. The recombinant MAP30 was identified by SDS-PAGE, Western blotting and LC-MS. After purification by nickel-affinity chromatography, The DNA-cleaving activity was analyzed by electrophoresis after supercoiled plasmid pUC19 as substrate treated with MAP30 of various concentrations. Meanwhile MAP30 was used to treat MCF-7 human breast tumor cells, MTT, DNA Ladder, AO/PI double-stained is used to detect the anti-tumor activity. Results show that map30 gene was successfully expressed in E. coli Rostta (DE3)and been identified by LC-MS and Western blot using His-tag mAb. First discovered through Escherichia coli heterologous expression of recombinant MAP30 like natural MAP30 protein also exert the activity conversion supercoiled plasmid pUC19 to relaxed or linear forms. The cytotoxicity assay of recombinant MAP30 showed that it exhibited dose-dependent and time-dependent inhibition to MCF-7, AO/PI double-stained displayed typical of apoptosis. It through genetic engineering technology preparation MAP30 protein to further study of its biological activities in vitro and laid important foundation for the future clinical application.

Key words: RIP Genetic engineering DNA cleavage Apoptosis

收稿日期: 2014-03-24 出版日期: 2014-06-25

ZTFLH:

Q789

基金资助:

湖南省教育厅重点项目（09A053）、湖南省教育厅委托项目（12W001）资助项目

通讯作者: 夏立秋 E-mail: xialq@hunnu.edu.cn

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

引用本文:

邱华丽, 穰杰, 丁学知, 胡胜标, 张友明, 朱道奇, 夏立秋. 苦瓜MAP30蛋白的原核表达及其生物活性研究[J]. 中国生物工程杂志, 2014, 34(06): 40-46.

QIU Hua-li, RANG Jie, DING Xue-zhi, HU Sheng-biao, ZHANG You-ming, ZHU Dao-qi, XIA Li-qiu. Prokaryotic Expression of MAP30 from Momordica charantia and Its Biological Activity. China Biotechnology, 2014, 34(06): 40-46.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20140606 或 https://manu60.magtech.com.cn/biotech/CN/Y2014/V34/I06/40

[1] Lee-Huang S, Huang P L, Nara P L, et al. MAP30: a new inhibitor of HIV-1 infection and replication. FEBS Letts, 1990, 272: 12-18.

[2] Lee-Huang S, Huang P L, Chen H C, et al. Anti-HIV and anti-tumor activities of recombinant MAP30 of bitter melon. Gene, 1995, 161: 151-156.

[3] Sikriwal D, Ghosh P, Batra J K. Ribosome inactivating protein saporin induces apoptosis through mitochondrial cascade, independent of translation inhibition. Int J Biochem Cell Biol, 2008, 4(12): 2880-2888.

[4] Ratna B, Amit R, Robert S, et al. Bitter melon(Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res, 2010, 70: 1925-1931.

[5] Peng R, Robert S, Pratibha V, et al. Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model. Cancer Prev Res, 2011, 4: 2122-2130.

[6] Fang E F, Ng T B. Bitter gourd(Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties. Curr Mol Med, 2011, 11: 417-436.

[7] Brennan V C, Wang C M, Yang W H. Bitter melon(Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor Type1 receptor/RAC-alpha serine/threonine-protein kinase signaling. J Med Food, 2012, 15: 325-334.

[8] Fang E F, Zhang C Z, Wong J H, et al. The MAP30 protein from bitter gourd(Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo. Cancer Lett, 2012, 324(1): 66-74.

[9] Meng Y, Liu S, Li J, et al. Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica charantia L. with covalent conjugation of polyethyelene glycol. Int J Nanomed, 2012, 7: 3133-3142.

[10] Fan J M, Luo J, Xu J, et al. Effects of recombinant MAP30 on cell proliferation and apoptosis of human colorectal carcinoma LoVo cells. Mol Biotechnol, 2008, 39: 79-86.

[11] Han X H, Xue Y J, Chen D Y, et al. Cloning, expression and functional analysis of MAP30 from Momordica charantia reveals its induction of apoptosis of the BGC-823 cells. Afr J Biotechnol, 2011, 10(78): 17925-17933.

[12] 熊术道, 尹丽慧, 李景荣, 等. 苦瓜籽RIP的分离纯化及其对K562细胞作用的研究. 中华中医药学刊, 2007, 25(1): 81-84. Xiong S D, Yin L H, Li J R, et al. Extraction and purification of ribosome inhibiting protein from Momordica charantia seeds and its effect of anti-tumor activity on erythroleukemic K562 cells. China Archi Trad Med, 2007,25(1):81-84.

[13] Sun Y T, Huang P L, Li J J, et al. Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with kaposi's, sarcoma-associated virus. Biochem Biophys Res Commun, 2001, 287(4): 983-994.

[14] Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin, 2013, 63: 11-30.

[15] Wang L, Lee I M, Zhang S M, et al. Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr, 2009, 89: 905-912.

[16] Wang S Z, Zheng Y Z, Yan J J, et al. Alpha-momorcharin: A ribosome-inactivating protein from Momordica charantia, possessing DNA cleavage properties. Protein & Peptide Lett, 2013, 20(11): 1257-1263.

[1]	彭向雷,王烨,王丽男,苏彦斌,付远辉,郑妍鹏,何金生. 单引物PCR法引入定点突变 ^*[J]. 中国生物工程杂志, 2020, 40(8): 19-23.
[2]	刘迪,张洪春. 慢性阻塞性肺疾病基因工程动物模型研究进展 ^*[J]. 中国生物工程杂志, 2020, 40(4): 59-68.
[3]	陈春琳,秦松,宋宛霖,刘志丹,刘正一. 褐藻寡糖生物法制备研究进展 ^*[J]. 中国生物工程杂志, 2020, 40(10): 85-95.
[4]	朱永朝,陶金,任萌萌,熊燃,何亚琴,周瑜,卢震辉,杜勇,杨芝红. 自噬抑制肿瘤坏死因子α诱导人胎盘胎儿来源间充质干细胞发生凋亡 ^*[J]. 中国生物工程杂志, 2019, 39(9): 62-67.
[5]	刘叶,潘玥,郑魏,胡晶. miR-186-5p在酒精诱导的心肌细胞中高表达并通过靶基因XIAP调控细胞凋亡水平 ^*[J]. 中国生物工程杂志, 2019, 39(5): 53-62.
[6]	马淑霞,张玲,闫晋飞,游松. 裂壶藻脂肪酸合酶途径合成多不饱和脂肪酸的研究 ^*[J]. 中国生物工程杂志, 2018, 38(9): 27-34.
[7]	贺雪婷,张敏华,洪解放,马媛媛. 大肠杆菌丁醇耐受机制及耐受菌选育研究进展 ^*[J]. 中国生物工程杂志, 2018, 38(9): 81-87.
[8]	陶宇,李高建,舒建洪,吴月红,杨芳,何玉龙. 猪支原体肺炎基因工程疫苗的研究进展 ^*[J]. 中国生物工程杂志, 2018, 38(2): 95-101.
[9]	石红璆,查代明,张炳火,李汉全. 全细胞脂肪酶研究进展 ^*[J]. 中国生物工程杂志, 2018, 38(11): 51-58.
[10]	吴锁伟,万向元. 利用生物技术创建主要作物雄性不育杂交育种和制种的技术体系[J]. 中国生物工程杂志, 2018, 38(1): 78-87.
[11]	代立婷, 吴忠南, 黄翔, 杨杰, 曾慧兰, 王国才, 蒋建伟. 卤地菊乙醇提取物W40单体诱导GLC-82细胞凋亡的分子机制研究[J]. 中国生物工程杂志, 2017, 37(8): 1-7.
[12]	郜娇娇, 杨树林. 基因工程技术优化透明质酸生产的研究进展[J]. 中国生物工程杂志, 2017, 37(8): 72-77.
[13]	徐安健, 李艳萌, 李斯文, 乌姗娜, 张蓓, 黄坚. PHP14沉默对肺癌细胞凋亡的影响及其机制[J]. 中国生物工程杂志, 2017, 37(7): 12-17.
[14]	尹舒贤, 赵月华, 刘超, 吕占军, 王秀芳. 人源Alu RNA工程菌的构建和表达[J]. 中国生物工程杂志, 2017, 37(7): 88-96.
[15]	王得华, 马义, 韩磊, 肖兴, 李艳伟, 党诗莹, 范志勇, 文涛, 洪岸. 新型基因重组PACAP衍生物MPL-2的制备及其抗2型糖尿病作用研究[J]. 中国生物工程杂志, 2017, 37(5): 59-65.

Viewed

Full text

Abstract

Cited

Shared

Discussed